Obesity Medicine • Neurometabolic Care
GLP-1 Care Beyond the Scale
GLP-1 Optimization & Physician-Led Obesity Medicine
Already taking a GLP-1 medication—or considering one? These medications can be powerful medical therapies, but prescribing the medication is only one part of thoughtful treatment. Dr. Myrna Cardiel provides individualized care with attention to medication strategy, nutrition, muscle and strength, body composition, metabolic health, side effects, sleep, and the long-term plan.
For patients who also experience migraine, brain fog, sleep problems, hormonal transitions, or other neurological symptoms, those concerns can be considered within the same broader medical perspective when clinically relevant.
Already receiving your medication elsewhere? You may still request an independent medical review and discuss whether ongoing management or transfer of prescribing care would be appropriate.
Three ways to begin
Care can meet you where you are
You do not need to fit into a one-size-fits-all program. The first step depends on whether you are already taking a medication, considering treatment, or seeking more detailed monitoring.
Already taking a GLP-1
Medication Review & Optimization
You do not need to start over because another clinician prescribed your medication. Dr. Cardiel can review your current drug, dose, response, weight trajectory, side effects, nutritional intake, medical history, other medications, and treatment goals.
When clinically appropriate, ongoing prescribing and medical management may also be discussed.
Considering treatment
GLP-1 & Obesity Medicine Consultation
A medical evaluation can help determine whether pharmacologic weight management is appropriate, which FDA-approved treatment options may be reasonable, and what monitoring should accompany treatment.
A consultation does not guarantee a prescription. Treatment recommendations follow an individualized medical evaluation.
Seeking deeper monitoring
Precision Neurometabolic Care
For selected patients, a more comprehensive approach may include body-composition monitoring, nutritional assessment, laboratory evaluation, glucose monitoring, exercise and strength assessment, sleep evaluation, bone-health assessment, or other testing when clinically useful.
Not every patient needs every test. Monitoring is individualized according to risk, goals, treatment response, and the clinical question being addressed.
Beyond scale weight
The medication may be working. But what exactly are you losing?
Meaningful weight reduction can improve health, but scale weight alone does not distinguish changes in fat mass from changes in lean tissue. A good treatment plan also considers how you are eating, moving, sleeping, functioning, and tolerating therapy.
Depending on the individual, useful questions may include:
What thoughtful management may include
A treatment plan built around health, not simply dose escalation
The scope of care is individualized. These are common domains that may be reviewed when they are relevant to treatment decisions.
Medication & Dose Strategy
Review of current treatment, response, tolerability, dose progression, other medications, goals, and whether continued escalation is actually necessary.
Nutrition, Protein & Hydration
Attention to reduced appetite, adequate intake, protein strategy, hydration, gastrointestinal symptoms, and practical nutrition during treatment.
Muscle, Strength & Function
Resistance exercise, strength, physical function, and preservation of lean tissue may be considered—especially during substantial or rapid weight reduction.
Metabolic & Cardiovascular Risk
Laboratory and clinical review may address glucose regulation, lipids, blood pressure, liver health, and other weight-related medical risks when appropriate.
Sleep, Recovery & Hormonal Context
Sleep apnea, sleep quality, menopausal transition, fertility treatment, recovery, and other physiologic factors may influence symptoms, appetite, and treatment goals.
Maintenance & Long-Term Strategy
Obesity is a chronic condition. The plan should include what happens after initial weight reduction, including maintenance, medication decisions, and sustainable habits.
Selective monitoring
Use the tool only when it answers a useful question
Not every patient needs CGM, DEXA, body-composition testing, HRV, or extensive laboratory panels. Testing is selected when the information is likely to influence treatment, clarify risk, or help monitor a meaningful outcome.
Laboratory Assessment
Selected metabolic, nutritional, endocrine, cardiovascular, or safety labs according to history and treatment.
Body Composition
SECA medical body-composition analysis or external DEXA when the result is clinically useful for monitoring lean and fat mass.
Glucose Monitoring
Continuous glucose monitoring may be considered in selected patients when it can answer a specific metabolic or behavioral question.
Strength & Exercise
Resistance-training frequency, functional measures, or other practical assessment may help focus muscle-preservation goals.
Bone Health
DEXA bone-density assessment may be considered when age, menopause, rapid weight change, medication history, or other risk factors warrant it.
Sleep & Wearables
Sleep assessment, heart-rate data, or other wearable information may be reviewed when it contributes meaningfully to the clinical picture.
The Cardiel Precision Brain Health difference
When GLP-1 treatment intersects with brain health
Dr. Cardiel brings together training in Neurology, Headache Medicine, Lifestyle Medicine, Obesity Medicine, and menopause-related neurological care. For selected patients, weight-management treatment may intersect with neurological symptoms rather than existing in a separate silo.
Care may consider changes in migraine or headache patterns, cognition and brain fog, sleep, hydration and nutritional status, neurological medications, physical activity, hormonal transitions, and metabolic health when clinically relevant.
Important: GLP-1 medications are not currently FDA-approved treatments for migraine. Early research examining GLP-1 pathways in migraine and headache disorders is interesting, but the evidence remains preliminary and additional clinical trials are needed.
Medical review matters
These are prescription medications—not a cosmetic shortcut
Before starting or continuing treatment, the medical review should consider whether the medication is appropriate for you, how it fits with your other conditions and medications, and what safety issues require discussion or monitoring.
- Medical history, weight-related conditions, current medications, prior weight-management treatment, and treatment goals
- Gastrointestinal symptoms, hydration, nutritional intake, and the pace of weight reduction
- Personal and family history relevant to medication contraindications or boxed warnings
- History of pancreatitis, gallbladder disease, kidney problems, diabetes-related eye disease, or other medication-specific risks when relevant
- Pregnancy plans, fertility treatment, contraception, and hormonal therapy when applicable
- Upcoming surgery or procedures requiring anesthesia or deep sedation, because medication-specific peri-procedural guidance may apply
Frequently asked questions
What patients often want to know
These answers are general. Medication choice, monitoring, and prescribing decisions are individualized after medical evaluation.
I already get Zepbound or Wegovy from another doctor. Can I still see Dr. Cardiel?
Yes. Patients already using GLP-1 or related obesity medications may request an independent medical review and optimization consultation. Dr. Cardiel can assess the current strategy and, when medically appropriate, discuss ongoing management or transfer of prescribing care.
Do I have to join a long-term weight-loss program?
No. Care can begin with a focused medical consultation. If longitudinal monitoring would be beneficial, the appropriate scope and follow-up can be discussed after the initial evaluation.
Will I need a CGM, DEXA scan, body-composition testing, or extensive labs?
Not necessarily. Monitoring is individualized. Some patients benefit from additional metabolic, body-composition, nutritional, sleep, or bone-health assessment; others do not require it. Testing is recommended when it is likely to influence treatment or monitoring.
Can Dr. Cardiel prescribe Zepbound, Wegovy, or other weight-management medications?
When medically appropriate after an individualized evaluation, Dr. Cardiel can prescribe FDA-approved obesity medications and provide ongoing medical management. A consultation does not guarantee that a particular medication will be prescribed.
Do I always need to keep increasing the GLP-1 dose?
No single dose strategy is right for every patient. Dosing depends on the specific medication, approved labeling, treatment response, tolerability, goals, and medical circumstances. The objective is an appropriate treatment strategy—not dose escalation for its own sake.
Can GLP-1 medications treat migraine?
GLP-1 medications are not currently FDA-approved treatments for migraine. Early clinical and mechanistic research is intriguing but remains investigational. Patients who have migraine and are using a GLP-1 medication for an appropriate medical indication can have both conditions considered together.
Does the practice compound or repackage GLP-1 medications?
No. Cardiel Precision Brain Health does not manufacture, compound, or repackage GLP-1 medications. Prescriptions are sent through appropriate licensed pharmacy or manufacturer channels according to the treatment plan.
Will insurance cover the medication or testing?
Coverage varies substantially by insurance plan, diagnosis, medication, pharmacy benefit, and testing facility. Cardiel Precision Brain Health is a direct-pay, out-of-network practice. Medication, laboratory, imaging, and external facility charges are separate from professional fees unless specifically stated otherwise.
Private, highly personalized care
Already on a GLP-1? Let’s make sure the treatment still makes sense.
In-person care is available in Midtown Manhattan, with telehealth appointments in New York, New Jersey, and Connecticut. Consultation requests are reviewed individually to determine whether your needs align with Dr. Cardiel’s clinical focus and model of care.
info@myrnacardielmd.com • Secure fax: 917-590-1737
This page provides general educational information and is not a substitute for individualized medical advice. Medication selection, prescribing, dosing, monitoring, testing, and treatment duration are determined after medical evaluation and may change as evidence and regulatory guidance evolve. Cardiel Precision Brain Health is a fee-for-service private practice and is not affiliated with NYU Langone Health.